— Know what they know.
Not Investment Advice

MNKD NASDAQ

MannKind Corporation
1W: +2.8% 1M: +20.8% 3M: -40.2% YTD: -40.9% 1Y: -24.1% 3Y: -24.6% 5Y: -23.2%
$3.38
+0.07 (+2.11%)
 
Weekly Expected Move ±14.2%
$2 $3 $3 $4 $4
NASDAQ · Healthcare · Biotechnology · Alpha Radar Buy · Power 61 · $1.0B mcap · 304M float · 2.26% daily turnover · Short 58% of daily vol

Revenue Segmentation

By Product / Service

Revenue by Segment (5-Year Trend)

Income Trends

Revenue
$349M +22.2% ▲
5Y CAGR: +39.9%
Gross Profit
$288M +37.8% ▲
5Y CAGR: +48.0%
Operating Income
$39M -46.5% ▼
Net Income
$6M -78.7% ▼
EPS (Diluted)
$0.02 -79.4% ▼
EBITDA
$28M -64.5% ▼

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2021FY2022FY2023FY2024FY2025
Revenue$75M$100M$199M$286M$349M
YoY Growth+15.8%+32.2%+99.4%+43.5%+22.2%
Cost of Revenue$39M$57M$63M$77M$61M
Gross Profit$37M$42M$136M$209M$288M
Gross Margin48.5%42.4%68.5%73.2%82.5%
R&D Expenses$12M$20M$31M$46M$66M
SG&A Expenses$77M$91M$94M$94M$144M
Operating Expenses$84M$106M$128M$136M$249M
Operating Income-$47M-$64M$9M$73M$39M
Operating Margin-62.3%-64.3%4.4%25.4%11.1%
Interest Expense$17M$25M$25M$38M$14M
Income Before Tax-$81M-$87M-$10M$31M$1M
Tax Expense$0$0$2M$3M-$4M
Net Income-$81M-$87M-$12M$28M$6M
Net Margin-107.3%-87.6%-6.0%9.7%1.7%
EPS (Diluted)$-0.37$-0.44$-0.04$0.10$0.02
EBITDA-$61M-$56M$15M$77M$28M
Shares Outstanding249M257M267M284M314M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms